{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:39:46Z","timestamp":1778945986153,"version":"3.51.4"},"reference-count":19,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T00:00:00Z","timestamp":1320883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> The scoring atopic dermatitis (SCORAD) is a well\u2010established severity\u2010scoring tool for atopic dermatitis (AD). Dead Sea climatotherapy (DSC) is a natural selective balneo\u2010phototherapy utilized for many years to treat severe AD. The study\u2019s goal was to evaluate the impact of DSC on AD patients through assessment of SCORAD scores and to identify parameters associated with greater improvement.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> The files of 78 European patients (37 male patients and 41 female patients, mean age 37.8\u2003years) with AD undergoing DSC were included in this retrospective study. Three sub\u2010groups were delineated based on disease severity (as determined using the SCORAD). Demographic and clinical parameters as well as treatment characteristics \u2013 maximal and cumulative sun exposure doses \u2013 were recorded. SCORAD values were again recorded for assessment of treatment response. SCORAD 75 was defined as \u226575% decrease in SCORAD values following therapy. Statistical analysis including logistic regression models was used in multivariable analysis.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> After an average of 30\u2003days of treatment, mean SCORAD values dropped from 50.5 to 11 (76.7%, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). 64.1% of all patients, regardless of sub\u2010group, reached SCORAD 75, whereas 78.9% of patients with severe disease achieved this result. In a multivariate logistic regression, factors associated with achieving SCORAD 75 were maximal sun exposure, family history of AD and age at disease onset (<jats:italic>P<\/jats:italic>\u2003=\u20030.002, <jats:italic>P<\/jats:italic>\u2003=\u20030.009 and <jats:italic>P<\/jats:italic>\u2003=\u20030.040 respectively).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Dead Sea climatotherapy is a particularly effective treatment method for the sub\u2010population of adults with severe AD. The SCORAD 75 can be useful for defining sub\u2010populations in which treatment is more likely to be successful.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2011.04331.x","type":"journal-article","created":{"date-parts":[[2011,11,10]],"date-time":"2011-11-10T06:30:32Z","timestamp":1320906632000},"page":"1510-1515","source":"Crossref","is-referenced-by-count":8,"title":["SCORAD 75: a new metric for assessing treatment outcomes in atopic dermatitis"],"prefix":"10.1111","volume":"26","author":[{"given":"M.","family":"Harari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dreiher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Czarnowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ruzicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ingber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000245677"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00651.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2006.02485.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2006.02513.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03415.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00840.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01683.x"},{"key":"e_1_2_6_9_2","first-page":"347","article-title":"Safety of solar phototherapy at the Dead Sea","volume":"38","author":"Kuschelevsky AP","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00286.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03278.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1080-1"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03486.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06343.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12251.x"},{"key":"e_1_2_6_16_2","first-page":"116","article-title":"Meta\u2010analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis","volume":"1","author":"Joohee Lee AB","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08112.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03351.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00204.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03857.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2011.04331.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2011.04331.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T08:37:13Z","timestamp":1697359033000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2011.04331.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,10]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1468-3083.2011.04331.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04331.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,10]]}}}